Novo Nordisk CDR (CAD Hedged) (NOVO:TSX) closed at $16.96 on October 23, 2026, down 1.28% on the day. The stock trades 38.5% below its 52-week high of $27.58 and 14.0% above its 52-week low of $14.88. Over the past year, it lost 16.6%. Novo Nordisk CDR (CAD Hedged) is part of the Health Care sector.
In 231 trading sessions since November 21, 2025, NOVO closed higher on 109 days (47%). Its best day was January 16, 2026 (+13.69%) and its worst was February 23, 2026 (-16.11%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 1 time.
Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Find more stocks like NOVO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.